Literature DB >> 6585460

Sialocystadenoma papilliferum of the palate.

J J Puts, R A Voorsmit, U J van Haelst.   

Abstract

The clinical and histological data concerning a case of sial -( ocyst )-adenoma papilliferum of the palate are presented. Ten cases of sialadenoma papilliferum have been reported to date. The lesion is characterized by several distinct clinical and histological features resembling in many aspects the syringocystadenoma papilliferum of the skin. Because of the invariable presence of more or less cystically dilated salivary gland ducts we propose to denote the lesion as sialocyst -adenoma papilliferum. Generally these neoplasms behave as benign tumours with an indolent and asymptomatic clinical course, although a single case of a malignant counterpart has been reported. An adequate local excision seems to be the treatment of choice. An accurate follow-up is required.

Entities:  

Mesh:

Year:  1984        PMID: 6585460     DOI: 10.1016/s0301-0503(84)80218-0

Source DB:  PubMed          Journal:  J Maxillofac Surg        ISSN: 0301-0503


  4 in total

Review 1.  [Rare sialadenoma papilliferum in the hard palate: case report and survey of the literature].

Authors:  C Wirz; M Bücheler; M Neid; A Dietz; M Fuchs
Journal:  HNO       Date:  2007-06       Impact factor: 1.284

2.  Sialadenoma Papilliferum: Analysis of Seven New Cases and Review of the Literature.

Authors:  Craig B Fowler; Douglas D Damm
Journal:  Head Neck Pathol       Date:  2017-09-08

Review 3.  Sialadenoma papilliferum: Bibliometric analysis.

Authors:  Antonio-Jorge-Araújo de Vasconcelos Ii; Luana-Rafaela Gerber; Stanny-Hagath-Maciel Saraiva; Pâmela-Oliveira de Vasconcelos; Lioney-Nobre Cabral; Tiago-Novaes Pinheiro
Journal:  J Clin Exp Dent       Date:  2019-09-01

4.  Sialadenoma papilliferum: clinicopathologic, Immunohistochemical, molecular analyses of new five cases and review of the literature.

Authors:  Shuai Chen; Jie Peng; Chuantao Yuan; Lin Sun; Renya Zhang; Yan Sun
Journal:  Diagn Pathol       Date:  2021-03-12       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.